Last updated on November 2018

Clostridium Difficile Vaccine Efficacy Trial


Brief description of study

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 60 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it is safe and well tolerated. Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium difficile infection.

Detailed Study Description

Clostridium Difficile

Clinical Study Identifier: NCT03090191

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Korea University Anam Hospital
Seoul, Korea, Republic of
1.92miles
  Connect »

Pfizer CT.gov Call Center

Hallym University Kangnam Sacred Heart Hospital
Seoul, Korea, Republic of
1.92miles
  Connect »

Pfizer CT.gov Call Center

Korea University Guro Hospital
Seoul, Korea, Republic of
1.92miles
  Connect »

Pfizer CT.gov Call Center

Hallym University Kangdong Sacred Heart Hospital
Seoul, Korea, Republic of
4.3miles
  Connect »

Pfizer CT.gov Call Center

Asan Medical Center
Songpa-gu, Korea, Republic of
9.17miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.